PMID: 9444979Aug 1, 1997Paper

Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV-1

Molecular Immunology
Z ProhászkaG Füst

Abstract

The transmembrane glycoprotein gp41 of HIV-1 contains a C1q binding domain (HIVenv 583-610) and activates the human complement system through the classical pathway. Based on structural and functional similarities between human defensins (human neutrophil peptide, HNP 1-3) and synthetic peptides representing the env 583-610 region of HIV-1, we found it interesting to investigate the C1q binding and complement activating ability of human defensins. Human defensins were purified and characterized by size exclusion chromatography, ultrafiltration, gel electrophoresis and HPLC. The complement activating ability of the purified peptides was assessed in a solid-phase immunoassay. Defensins, fixed to an ELISA plate, were able to bind the C1q subcomponent of the first complement component (C1), triggering the classical pathway of complement activation which led to C4b binding to the plate. Reduction and subsequent alkylation of disulfide bridges of defensins greatly decreased the C1q binding ability but complement activation (C4b binding) remained high. Further acetylation of the reduced defensin peptide resulted in a molecule which bound very little or no C1q but still activated the complement cascade. These phenomena indicate that def...Continue Reading

References

Oct 16, 1975·Nature·R M WelshM B Oldstone
Mar 1, 1978·The Journal of Experimental Medicine·R M BartholomewH J Müller-Eberhard
Jan 1, 1990·European Journal of Haematology·T GanzR I Lehrer
Jan 24, 1985·Nature·L RatnerK Baumeister
Oct 1, 1985·The Journal of Clinical Investigation·T GanzR I Lehrer
Dec 1, 1986·Journal of Virology·K A DaherR I Lehrer
Apr 21, 1988·Nature·A R Duncan, G Winter
May 1, 1985·Diagnostic Microbiology and Infectious Disease·J FleischmannR I Lehrer
Dec 19, 1994·FEBS Letters·A V PanyutichT Ganz
Aug 1, 1994·Current Opinion in Immunology·T Ganz, R I Lehrer
Jun 1, 1994·Clinical Immunology and Immunopathology·C R Monell, M Strand
Sep 1, 1993·Immunology Today·M P DierichG J Arlaud
Dec 1, 1993·Clinical and Experimental Immunology·T HidvégiG Füst
Jan 1, 1993·Annual Review of Immunology·R I LehrerT Ganz
Aug 1, 1995·Current Opinion in Structural Biology·S H WhiteM E Selsted

❮ Previous
Next ❯

Citations

May 20, 1999·Biopolymers·D Andreu, L Rivas
Oct 11, 2002·The Journal of Pathology·Friedrich PaulsenWolf Petersen
Feb 27, 1999·Current Opinion in Immunology·A Nicholson-Weller, L B Klickstein
Jun 20, 2002·Trends in Immunology·De YangJoost J Oppenheim
Sep 17, 2004·Nature Reviews. Microbiology·Robert I Lehrer
Apr 20, 2002·Plastic and Reconstructive Surgery·Charles P ChaleksonJesse Jaynes
Feb 5, 2002·Annual Review of Physiology·Brian C Schutte, Paul B McCray
Jan 6, 2009·Ophthalmic Research·Alison M McDermott
Apr 14, 2009·American Journal of Respiratory and Critical Care Medicine·Kazuhisa KonishiNaftali Kaminski
Mar 15, 2002·Cell Stress & Chaperones·Zoltán ProhászkaGeorge Füst
Nov 19, 2008·Molecular Medicine·Roland PálffyPeter Celec
Jul 23, 2003·Immunology·Niubel Diaz PadillaC Erik Hack
Aug 2, 2002·Expert Opinion on Investigational Drugs·Jim A Turpin
Nov 4, 2006·FEMS Microbiology Letters·Xiaoying LuKim A Brogden
May 18, 2004·FEMS Immunology and Medical Microbiology·Ørjan SamuelsenLars H Vorland
Jan 16, 2009·Trends in Immunology·A P SjöbergA M Blom
Dec 3, 2005·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Deike VarogaFriedrich Paulsen
Sep 25, 2004·Immunology Letters·Uday KishoreAlok Agrawal
Nov 3, 1998·Lancet·Z Prohászka, G Füst
Jan 27, 2018·Journal of Fungi·Akash VermaMarc Swidergall
Sep 27, 2019·Antibiotics·Maria Paula Gomez HernandezKim A Brogden
Apr 30, 2016·Bioorganicheskaia khimiia·M N BerlovV N Kokryakov
Feb 23, 2012·Viruses·Alexander W TarrJonathan K Ball
Jan 10, 2020·Autoimmunity·Ekaterina S UmnyakovaVladimir N Kokryakov
Jun 3, 2005·Cancer Research·Jinguo ChenLurong Zhang
Oct 30, 2001·The Medical Clinics of North America·D A Welsh, C M Mason

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.